Forglyn Respicap are used for the long-term management of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). It contains formoterol fumarate and glycopyrrolate / glycopyrronium, which help to open the airways, making it easier to breathe and reducing symptoms like wheezing and shortness of breath.
In addition to managing COPD, this medicine can also help manage symptoms related to chronic bronchitis and emphysema. However, this medicine is not recommended for the relief of sudden breathing problems or the treatment of asthma.
